Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 6/20 | 0.61 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.39 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.39 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 5/20 | 0.38 |
| ▸ | IL1B | P01584 | 4/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.37 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26436315 | 0.93 | NLRP3 (0.60) | NLRP3CSNK2A2CSNK2BCSNK2A1ROCK2 | |
| SCHEMBL26437605 | 0.89 | NLRP3 (0.55) | NLRP3IL1BGABRA5PIK3CD | |
| SCHEMBL26436334 | 0.88 | NLRP3 (0.46) | NLRP3ROCK2IL1BPIK3CD | |
| SCHEMBL26436297 | 0.86 | NLRP3 (0.81) | NLRP3IL1B | |
| SCHEMBL26436765 | 0.84 | NLRP3 (0.52) | NLRP3IL1BGABRA5PIK3CD | |
| SCHEMBL26436319 | 0.83 | NLRP3 (0.60) | NLRP3CSNK2A2CSNK2BCSNK2A1ROCK2 | |
| SCHEMBL29275846 | 0.83 | NLRP3 (0.81) | NLRP3IL1B | |
| SCHEMBL30214151 | 0.83 | NLRP3 (0.81) | NLRP3IL1B | |
| SCHEMBL26437146 | 0.81 | NLRP3 (0.58) | NLRP3GABRA5 | |
| SCHEMBL26437428 | 0.81 | NLRP3 (0.50) | NLRP3IL1BGABRA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023066377-A1 | NITROGEN-CONTAINING COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 索智生物科技(浙江)有限公司 | 2023-04-27 | — | — | WO | disclosed |